L005 (Divalproex Sodium Delayed-Release 125 mg)

Pill with imprint L005 is Purple, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 125 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Divalproex sodium is used in the treatment of bipolar disorder; migraine prevention; mania; epilepsy; borderline personality disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for L005

Divalproex Sodium Delayed-Release

Imprint:

L005

Strength:

125 mg

Color:

Purple

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Lupin Pharmaceuticals, Inc

Inactive Ingredients:

microcrystalline cellulose
D&C Red No. 30
FD&C Blue No. 2
ferric oxide yellow
ferrosoferric oxide
hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
hypromellose phthalate (24% phthalate, 55 cst)
hypromelloses
magnesium stearate
propylene glycol
shellac
silicon dioxide
pregelatinized corn starch
magnesium silicate
titanium dioxide
triethyl citrate
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer